Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma

Kim,Hyungjoo; Ahn,Tae  Sung; Kim,Chang‑Jin; Bae,Sang  Byung; Kim,Han  Jo; Lee,Chang‑Seuk; Kim,Tae  Hyun; Im,Jungkyun; Lee,Sang  Hun; Son,Myoung  Won; Lee,Moon  Soo; Baek,Moo  Jun; Jeong,Dongjun

doi:10.3892/ol.2017.6203

Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma

Authors:
- Hyungjoo Kim
- Tae Sung Ahn
- Chang‑Jin Kim
- Sang Byung Bae
- Han Jo Kim
- Chang‑Seuk Lee
- Tae Hyun Kim
- Jungkyun Im
- Sang Hun Lee
- Myoung Won Son
- Moon Soo Lee
- Moo Jun Baek
- Dongjun Jeong
View Affiliations

Affiliations: Soonchunhyang Medical Science Research Institute, College of Medicine, Soonchunhyang University, Dongnam‑gu, Cheonan, Chungcheongnam‑do 330‑721, Republic of Korea, Department of Surgery, College of Medicine, Soonchunhyang University, Dongnam‑gu, Cheonan, Chungcheongnam‑do 330‑721, Republic of Korea, Department of Pathology, College of Medicine, Soonchunhyang University, Dongnam‑gu, Cheonan, Chungcheongnam‑do 330‑721, Republic of Korea, Department of Oncology, College of Medicine, Soonchunhyang University, Dongnam‑gu, Cheonan, Chungcheongnam‑do 330‑721, Republic of Korea, Department of Chemistry, Soonchunhyang University, Shinchang‑myeon, Asansi, Chungcheongnam‑do 336‑745, Republic of Korea, Department of Nanochemical Engineering, Soonchunhyang University, Shinchang‑myeon, Asansi, Chungcheongnam‑do 336‑745, Republic of Korea, Department of Biochemistry, College of Medicine, Soonchunhyang University, Dongnam‑gu, Cheonan, Chungcheongnam‑do 330‑721, Republic of Korea
Published online on: May 18, 2017 https://doi.org/10.3892/ol.2017.6203
Pages: 553-560
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiopoietin-2 (Ang-2) has been investigated in cancer primarily in terms of its angiogenic function, and its role as an oncogene has yet to be elucidated. The current study hypothesized that Ang‑2 may be an oncogene and have a function in tumor progression. An investigation of the function of Ang‑2 in the LoVo colorectal cancer (CRC) cell line in vitro, which expresses a high level of Ang‑2, was performed by knocking down endogenous expression with a targeted short hairpin RNA. The aggressive phenotypic effects of Ang‑2 on experimental and control group cells were assessed using cell proliferation, migration and invasion assays. The association between Ang‑2 expression levels and clinicopathological factors was evaluated in 415 CRC tissues using immunohistochemistry. Suppressing Ang‑2 expression decreased cellular proliferation, invasion and migration in an in vitro study. Ang‑2 overexpression was observed in 46% of patients with CRC and was significantly associated with pT (P=0.048), pN (P<0.001), venous invasion (P=0.023), lymphatic invasion (P<0.001) and tumor‑node‑metastasis stage (P=0.022). Furthermore, Ang‑2 overexpression was an independent prognostic factor in pN stages 1 and 2. These results reveal that Ang‑2 may be an oncogene in colorectal carcinogenesis and its expression may exert aggressive phenotypic effects during tumor progression. In addition, Ang‑2 expression may serve as a prognostic marker and a potential drug target.

View Figures

View References

1	Fiedler U, Krissl T, Koidl S, Weiss C, Koblizek T, Deutsch U, Martiny-Baron G, Marmé D and Augustin HG: Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem. 278:1721–1727. 2003. View Article : Google Scholar : PubMed/NCBI
2	Hu B and Cheng SY: Angiopoietin-2: Development of inhibitors for cancer therapy. Curr Oncol Rep. 11:111–116. 2009. View Article : Google Scholar : PubMed/NCBI
3	Rykala J, Przybylowska K, Majsterek I, Pasz-Walczak G, Sygut A, Dziki A and Kruk-Jeromin J: Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables. Pathol Oncol Res. 17:809–817. 2011. View Article : Google Scholar : PubMed/NCBI
4	Zhang ZL, Liu ZS and Sun Q: Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol. 12:4241–4245. 2006. View Article : Google Scholar : PubMed/NCBI
5	Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano T, Li M, Otake Y and Wada H: Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res. 62:7124–7129. 2002.PubMed/NCBI
6	Moom WS, Park HS, Yu KH, Jang KY, Kang MJ, Park H and Tarnawski AS: Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: Implication for angiogenesis. J Korean Med Sci. 21:272–278. 2006. View Article : Google Scholar : PubMed/NCBI
7	Helfrch I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D and Augustin HG: Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res. 15:1384–1392. 2009. View Article : Google Scholar : PubMed/NCBI
8	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
9	Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG and Lee JS: Cancer statistics in Korea: Incidence, mortality, survival and prevalence in 2010. Cancer Res Treat. 45:1–14. 2013. View Article : Google Scholar : PubMed/NCBI
10	Goldberg RM: Therapy for metastatic colorectal cancer. Oncologist. 11:981–987. 2006. View Article : Google Scholar : PubMed/NCBI
11	Haddad AJ, Hani M Bani, Pawlik TM and Cunningham SC: Colorectal liver metastases. Int J Surg Oncol. 2011:2858402011.PubMed/NCBI
12	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
13	Scott AM, Wolchok JD and Old LJ: Antibody therapy of cancer. Nat Rev Cancer. 12:278–287. 2012. View Article : Google Scholar : PubMed/NCBI
14	Ahmad SA, Liu W, Jung YD, Fan F, Wilson M, Reinmuth N, Shaheen RM, Bucana CD and Ellis LM: The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res. 61:1255–1259. 2001.PubMed/NCBI
15	Rigamonti N, Kadioglu E, Keklikoglou I, Rmili C Wyser, Leow CC and De Palma M: Role of angiopoietin-2 in adaptive tumor resistance to VEGF Signaling Blockade. Cell Rep. 8:696–706. 2014. View Article : Google Scholar : PubMed/NCBI
16	Rankin EB and Giaccia AJ: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15:678–685. 2008. View Article : Google Scholar : PubMed/NCBI
17	Peters KG: Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel. Circ Res. 83:342–343. 1998. View Article : Google Scholar : PubMed/NCBI
18	Li C, Sun CJ, Fan JC, Geng N, Li CH, Liao J, Mi K, Zhu GQ, Ma H, Song YF, et al: Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma. Med Oncol. 30:5712013. View Article : Google Scholar : PubMed/NCBI
19	Ochiumi T, Tanaka S, Oka S, Hiyama T, Ito M, Kitadai Y, Haruma K and Chayama K: Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Oncol. 24:539–547. 2004.PubMed/NCBI
20	Scharpfenecker M, Fiedler U, Reiss Y and Augustin HG: The Tie-2 ligand angiopietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 15:771–780. 2005. View Article : Google Scholar
21	Ahmad SA, Liu W, Jung YD, Fan F, Reinmuth N, Bucana CD and Ellis LM: Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer. 92:1138–1143. 2001. View Article : Google Scholar : PubMed/NCBI
22	Kahlert C, Pecqueux M, Halama N, Dienemann H, Muley T, Pfannschmidt J, Lasitschka F, Klupp F, Schmidt T, Rahbari N, et al: Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. Br J Cancer. 110:441–449. 2014. View Article : Google Scholar : PubMed/NCBI
23	Avraham HK, Jiang S, Fu Y, Nakahatri H, Ovadia H and Avraham S: Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain. J Pathol. 232:369–381. 2014. View Article : Google Scholar : PubMed/NCBI
24	Shim WS, Ho IA and Wong PE: Angiopoietin: A TIE(d) balance in tumor angiogenesis. Mole Cancer Res. 5:655–665. 2007. View Article : Google Scholar
25	Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD and Cheng SY: Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res. 66:775–783. 2006. View Article : Google Scholar : PubMed/NCBI
26	Nasarre P, Thomas M, Kruse K, Helfrich I, Wolter V, Deppermann C, Schadendorf D, Thurston G, Fiedler U and Augustin HG: Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth. Cancer Res. 69:1324–1333. 2009. View Article : Google Scholar : PubMed/NCBI
27	Wang HL, Deng CS, Lin J, Pan Dy, Zou Zy and Zhou XY: Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. Tohoku J Exp Med. 213:33–40. 2007. View Article : Google Scholar : PubMed/NCBI
28	Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
29	Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S and Mori M: Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases. Cancer Res. 61:2145–2153. 2001.PubMed/NCBI